{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:08:30Z","timestamp":1788376110451,"version":"build-2803163510"},"reference-count":45,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DA040189"],"award-info":[{"award-number":["5R01DA040189"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24DA042720"],"award-info":[{"award-number":["K24DA042720"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic pain affects one-fifth of US adults. Reductions in opioid prescribing have been associated with increased non-prescription opioid use and, chronologically, increased stimulant (methamphetamine and cocaine) use. While non-prescription opioid use is commonly attributed to pain self-management, the role of stimulants in managing pain is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed baseline data from a longitudinal study of patients with chronic non-cancer pain in an urban safety-net healthcare system who had been prescribed an opioid for \u22653 of the last 12\u2009months, and had a history of non-prescription opioid, cocaine, or amphetamine use ( N\u2009=\u2009300). We estimated the prevalence and identified correlates of stimulant use to treat pain among a subgroup of patients who reported past-year stimulant use ( N\u2009=\u2009105). Data sources included computer-assisted questionnaire (demographics, substance use, pain), clinical exam and procedures (pain, pain tolerance), and chart abstraction (opioid prescriptions). We conducted bivariate analyses to assess associations between demographics, pain characteristics, non-opioid therapies, substance use, opioid prescriptions, and self-reported symptoms, with reporting using stimulants to treat pain. Demographic variables and those with significant bivariate associations were included in a multivariable logistic regression model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-two percent of participants with past-year stimulant use reported using stimulants in the past year to treat pain. Participants who used stimulants for pain reported slightly higher average pain in the past 3\u2009months (median of 8 (IQR: 6\u20138) vs 7 (7\u20139) out of 10, p\u2009=\u20090.049). In the multivariable analysis, female gender (AOR= 3.20, 95% CI: 1.06\u20139.63, p\u2009=\u20090.039) and higher score on the Douleur Neuropathique 4 neuropathic pain questionnaire (AOR = 1.34, 95% CI: 1.05\u20131.70, p\u2009=\u20090.017) were associated with past-year stimulant use to treat pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Stimulants may be used for pain self-management, particularly for neuropathic pain and among women. Our findings suggest an underexplored motivation for stimulant use in an era of reduced access to prescribed opioids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2021.1903654","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T13:18:01Z","timestamp":1617369481000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":18,"title":["Stimulant use for Self-Management of Pain among Safety-Net Patients with Chronic Non-Cancer Pain"],"prefix":"10.1177","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-1909","authenticated-orcid":false,"given":"Cathleen M.","family":"Beliveau","sequence":"first","affiliation":[{"name":"Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"McMahan","sequence":"additional","affiliation":[{"name":"Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Arenander","sequence":"additional","affiliation":[{"name":"Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Angst","sequence":"additional","affiliation":[{"name":"Department of Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Kushel","sequence":"additional","affiliation":[{"name":"University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Torres","sequence":"additional","affiliation":[{"name":"Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn-Milo","family":"Santos","sequence":"additional","affiliation":[{"name":"Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA"},{"name":"University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip O.","family":"Coffin","sequence":"additional","affiliation":[{"name":"Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA"},{"name":"University of California San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6736a2"},{"key":"bibr2-08897077.2021.1903654","unstructured":"Centers for Disease Control and Prevention. U.S. Opioid presccribing rate maps. Opioid Overdose Web site. https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate-maps.html. Published 2020. Updated March 5, 2020. Accessed March 31, 2020."},{"key":"bibr3-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232538"},{"key":"bibr4-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.031"},{"key":"bibr5-08897077.2021.1903654","unstructured":"Centers for Disease Control and Prevention. HIV infection, risk, prevention, and testing behaviors among persons who inject drugs: national HIV behavioral surveillance injection drug use 20\u2009US Cities, 2012. Atlanta, GA: GeorgiaCenters for Disease Control and Prevention (CDC); 2012."},{"key":"bibr6-08897077.2021.1903654","unstructured":"Centers for Disease Control and Prevention. HIV infection, risk, prevention, and testing behaviors among persons who inject drugs: national HIV behavioral surveillance injection drug use 20\u2009US Cities, 2015. Atlanta, GA: GeorgiaCenters for Disease Control and Prevention (CDC); 2015."},{"key":"bibr7-08897077.2021.1903654","volume-title":"San Francisco Annual Report: Substance Use Pattern and Trends Through 2018","author":"Coffin PO","year":"2019"},{"key":"bibr8-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.2217\/pmt.13.62"},{"key":"bibr9-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230408"},{"key":"bibr10-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0b013e328331ba5b"},{"key":"bibr11-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91633-8"},{"key":"bibr12-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197703312961303"},{"key":"bibr13-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90031-1"},{"key":"bibr14-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000593"},{"key":"bibr15-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2006.07.003"},{"key":"bibr16-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12701"},{"key":"bibr17-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2010.09.030"},{"key":"bibr18-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2018.10.008"},{"key":"bibr19-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.010"},{"key":"bibr20-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-323-7_13"},{"key":"bibr21-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03500.x"},{"key":"bibr22-08897077.2021.1903654","unstructured":"Michael JLS. The pain catastrophizing scale: user manual. 1995. https:\/\/sullivan-painresearch.mcgill.ca\/pdf\/pcs\/PCSManual_English.pdf."},{"issue":"144","key":"bibr23-08897077.2021.1903654","first-page":"197","volume":"26","author":"Oaks Z","year":"2018","journal-title":"Discov Med"},{"key":"bibr24-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12129"},{"key":"bibr25-08897077.2021.1903654","unstructured":"Centers for Disease Control and Prevention. calculating total daily dose of opioids for safer dosage. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/prescribing\/Guidelines_Factsheet-a.pdf. Published 2019."},{"key":"bibr26-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3945"},{"key":"bibr27-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1185\/135525703125002360"},{"key":"bibr28-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.7877"},{"key":"bibr29-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"bibr30-08897077.2021.1903654","first-page":"1","author":"Wu Y","year":"2019","journal-title":"Psychol Med"},{"key":"bibr31-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026"},{"key":"bibr32-08897077.2021.1903654","first-page":"1","volume-title":"The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Volume 3: Instruments for Adults","author":"Derogatis LR","year":"2004"},{"key":"bibr33-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.11.008"},{"key":"bibr34-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.08.013"},{"key":"bibr35-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.03.002"},{"key":"bibr36-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/S1550-8579(08)80005-8"},{"key":"bibr37-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9724371"},{"key":"bibr38-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1177\/0004867416634208"},{"key":"bibr39-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1177\/0004867420924076"},{"key":"bibr40-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000723"},{"key":"bibr41-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2016.1271432"},{"key":"bibr42-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1080\/16066350500270901"},{"key":"bibr43-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12116"},{"key":"bibr44-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-013-0657-z"},{"key":"bibr45-08897077.2021.1903654","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.02.018"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1903654","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2021.1903654","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2021.1903654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:54:44Z","timestamp":1777625684000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2021.1903654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2021.1903654"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2021.1903654","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}